Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

MEN 15596

Known as: MEN-15596, MEN15596 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
We have characterized the pharmacological profile of the nonpeptide tachykinin NK2 receptor antagonist ibodutant (MEN15596… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
2013
2013
In this study we have characterized the pharmacological profile of the non-peptide tachykinin NK2 receptor antagonist ibodutant… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2013
2013
In this study we have characterized the pharmacological profile of the non-peptide tachykinin NK(2) receptor antagonist ibodutant… Expand
Is this relevant?
2013
2013
We recently identified hexamethonium-resistant peristalsis in the guinea pig colon. We showed that, following acute blockade of… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
Ibodutant (MEN15596, [1-(2-phenyl-1R-{[1-(tetrahydropyran-4-ylmethyl)-piperidin-4-ylmethyl]-carbamoyl}-ethylcarbamoyl… Expand
  • figure 1
  • figure 3
  • figure 2
  • table 1
  • figure 4
Is this relevant?
2007
2007
Starting from 1 (MEN14268), a selective tachykinin NK2 receptor antagonist with an interesting in vitro pharmacological profile… Expand
Is this relevant?
2006
2006
The pharmacological profile of MEN15596 or (6-methyl-benzo[b]thiophene-2-carboxylic acid [1-(2-phenyl-1R-{[1-(tetrahydropyran-4… Expand
Is this relevant?